Back to Search
AARTI JANI, M.D.
M.D.
Internal Medicine Physician
NPI: 1245541119IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
125.058147(IL)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 2010
Research & Publications (20)
Phenotyping of cytochrome P450 3A enzyme in Gujarat population.
PMID 19356063·Drug Metab Lett·2008
3-trial
Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields.
PMID 16983394·Prostate Cancer Prostatic Dis·2007
4-observational
Influence of intensity-modulated radiotherapy on acute genitourinary and gastrointestinal toxicity in the treatment of localized prostate cancer.
PMID 17241095·Technol Cancer Res Treat·2007
4-observational
Role of androgen ablation with low-dose-rate brachytherapy in the treatment of prostate cancer.
PMID 17274679·Clin Drug Investig·2006
8-other
Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity.
PMID 16413351·Urology·2006
4-observational
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
PMID 16635512·Urology·2006
4-observational
Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysis.
PMID 15756656·Cancer·2005
6-review
Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis.
PMID 15708246·Int J Radiat Oncol Biol Phys·2005
8-other
Impact on late toxicity of using transabdominal ultrasound for prostate cancer patients treated with intensity modulated radiotherapy.
PMID 15649095·Technol Cancer Res Treat·2005
8-other
Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy.
PMID 16140079·Urology·2005
8-other
Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings.
PMID 15992908·Urology·2005
4-observational
Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer.
PMID 15983626·Prostate Cancer Prostatic Dis·2005
8-other
Opacity transfer function optimization for volume-rendered computed tomography images of the prostate.
PMID 15935974·Acad Radiol·2005
8-other
Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer.
PMID 15913725·Urology·2005
8-other
Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapy.
PMID 15780365·Urology·2005
8-other
The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer.
PMID 15571465·Expert Opin Pharmacother·2004
6-review
Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysis.
PMID 15533489·Urology·2004
1-meta
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.
PMID 15299055·J Nucl Med·2004
4-observational
Analysis of prostate-specific antigen rebound interval in patients with prostate cancer receiving hormonal therapy and external-beam radiation therapy.
PMID 15279690·Clin Prostate Cancer·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 ERIE CT, SUITE L700
OAK PARK, IL 60302 - Phone
- (708) 763-1471
Quick Facts
- NPI
- 1245541119
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile